Evidence reviews on sleep quality, duration, and disorders.
33 claims reviewed
Strong evidence confirms that alcohol consumption disrupts sleep architecture, particularly in the second half of the night. Even moderate doses suppress REM sleep, increase sleep fragmentation, and worsen sleep-disordered breathing. The sedative onset masks significant sleep quality impairment.
Moderate evidence shows that blue light from screens suppresses melatonin production and can delay sleep onset, but the effect size is smaller than popularly believed. Screen use habits (stimulating content, scrolling) likely matter more than the light itself.
Meta-analyses and head-to-head RCTs demonstrate that CBT-I produces comparable short-term improvements to sleeping pills, with superior long-term outcomes and durable effects after treatment ends. Major guidelines now recommend CBT-I as first-line treatment for chronic insomnia.
Weak evidence from small RCTs suggests chamomile may produce modest improvements in subjective sleep quality, but effect sizes are small and most studies have methodological limitations. Objective polysomnography data are largely absent.
Strong evidence establishes CBT-I as the gold-standard first-line treatment for chronic insomnia. Multiple meta-analyses demonstrate clinically significant improvements in sleep onset latency, wake after sleep onset, and sleep efficiency that persist long after treatment ends.
Weak evidence for earthing improving sleep quality. Available studies suffer from extremely small sample sizes, inadequate blinding, high risk of bias, and lack of plausible biological mechanism beyond placebo effects. No rigorous RCTs support the practice for sleep outcomes.
Moderate evidence from several small RCTs suggests glycine (3g before bed) improves subjective sleep quality, reduces next-day fatigue, and decreases sleep onset latency. The mechanism involves core body temperature reduction via peripheral vasodilation.
Moderate evidence suggests writing a to-do list or expressive journal before bed reduces sleep onset latency by 5-15 minutes. The mechanism appears to involve cognitive offloading—externalizing worries and unfinished tasks reduces pre-sleep rumination.
Strong evidence supports morning sunlight exposure for improving sleep quality by anchoring circadian rhythms. Bright light in the first 1-2 hours after waking advances melatonin onset, consolidates sleep architecture, and is an established treatment for circadian rhythm disorders.
Very weak evidence supports mouth taping for sleep improvement. Only a handful of small studies exist, mostly in snoring or mild sleep apnea populations. Claims about benefits for healthy individuals are largely anecdotal with no rigorous clinical support.
Weak evidence supports mouth taping for snoring reduction. Only a handful of small studies exist, showing modest decreases in snoring severity in mild cases. The practice lacks rigorous clinical validation and carries theoretical risks for individuals with nasal obstruction.
Short naps of 10-20 minutes consistently improve alertness, reaction time, and working memory. Longer naps (>30 min) can cause sleep inertia and may impair performance immediately after waking.
Moderate evidence suggests that reading a physical book before bed can improve sleep onset latency and subjective sleep quality, likely through cognitive distraction from rumination and reduction of pre-sleep arousal. E-reader screens may partially negate benefits due to blue light emission.
Consistent observational evidence links screen use to reduced sleep duration and poorer sleep quality in adolescents. However, effect sizes are generally small, and some research suggests the relationship may be overstated, with technology use explaining only a fraction of sleep variability.
Moderate evidence suggests sexual activity before sleep, particularly with orgasm, improves perceived sleep quality and reduces sleep onset latency. The proposed mechanism involves post-orgasmic release of oxytocin and prolactin with concurrent suppression of cortisol, though objective polysomnographic evidence is limited.
Weak evidence for this specific claim. Sleep architecture is determined by time since sleep onset, not clock time. However, earlier sleep timing aligns better with circadian biology for most people, yielding more slow-wave sleep in early cycles regardless of when those cycles begin.
Strong evidence firmly establishes that sleep is essential for memory consolidation. Both slow-wave sleep and REM sleep play distinct, complementary roles in stabilizing declarative and procedural memories, with sleep deprivation consistently impairing learning retention.
Strong observational evidence confirms obstructive sleep apnea (OSA) significantly increases cardiovascular risk including hypertension, stroke, heart failure, and cardiac death. However, treating OSA with CPAP has not clearly reduced cardiovascular events in large RCTs, creating a treatment paradox.
Strong evidence supports that sleep deprivation promotes weight gain through multiple mechanisms including increased appetite hormones, greater caloric intake, reduced energy expenditure, and impaired glucose metabolism. Both short-term experiments and long-term cohort studies consistently show this relationship.
Moderate evidence suggests chronic sleep restriction causes lasting metabolic, cognitive, and cardiovascular changes that are not fully reversible with recovery sleep. Short-term sleep debt is largely recoverable, but years of insufficient sleep may cause persistent alterations in inflammatory markers and brain structure.
Strong evidence demonstrates that sleep deprivation significantly impairs immune function. Both acute and chronic sleep restriction reduce natural killer cell activity, impair vaccine antibody responses, increase inflammatory markers, and elevate susceptibility to infectious illness.
Experimental studies demonstrate that sleep deprivation impairs wound healing through immune suppression and altered growth hormone release. While mechanistic evidence is compelling, clinical studies in real-world wound care populations remain limited.
Strong mechanistic and epidemiological evidence links chronic sleep deprivation to increased Alzheimer's disease risk through impaired glymphatic clearance of beta-amyloid and tau proteins during sleep.
Strong evidence supports sleep extension (obtaining more than habitual sleep) for improving athletic performance. Studies in basketball, swimming, tennis, and other sports show improvements in reaction time, sprint speed, accuracy, and mood when athletes extend sleep to 9-10 hours nightly.
Moderate evidence suggests sleep position affects specific health conditions. Lateral (side) sleeping improves glymphatic clearance and reduces sleep apnea severity. Supine position worsens snoring and acid reflux. Evidence for long-term disease outcomes is limited.
Strong evidence demonstrates that poor sleep quality and short sleep duration impair immune function, increasing susceptibility to infections. Experimental studies show causal links between sleep restriction and reduced vaccine responses, natural killer cell activity, and increased infection rates.
Moderate evidence suggests sleep regularity (consistent sleep/wake timing) is an independent predictor of health outcomes and may be comparably or more important than total sleep duration for cardiometabolic health and mortality. However, both dimensions matter and the evidence is primarily observational.
Strong evidence supports sleep restriction therapy as an effective component of CBT-I for chronic insomnia. It improves sleep efficiency, reduces time awake in bed, and produces durable improvements. It is considered a first-line behavioral treatment.
Strong evidence that sleep extension (increasing sleep to 9-10 hours) improves reaction time, sprint speed, accuracy, and mood in athletes. Sleep restriction consistently impairs performance. Most athletes are chronically sleep-deprived, making additional sleep a high-impact intervention.
Weak evidence suggests consumer sleep trackers do not meaningfully improve sleep quality and may worsen it in some individuals. The phenomenon of 'orthosomnia'—anxiety about achieving perfect sleep scores—has been documented in clinical case reports, and no controlled trials demonstrate improved sleep outcomes from tracking alone.
Weak evidence suggests morning chronotype is associated with lower depression risk, but the relationship is correlational and confounded by social factors. A genetic Mendelian randomization study found modest depression risk reduction with earlier wake times, but forced early rising in night owls may worsen rather than improve mental health.
Moderate evidence suggests weighted blankets improve subjective sleep quality and reduce insomnia severity, particularly in individuals with anxiety. Objective sleep measures (polysomnography) show less consistent improvements than self-reported outcomes.
Moderate evidence suggests melatonin is safe for short-to-medium term use (up to 3-6 months) with minimal side effects. Long-term safety data (>1 year) is limited but available studies show no major concerns.